Fharat A. Raja
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Impact of Immunotherapy Addition on Dose Density and Clinical Outcomes of Neoadjuvant Chemotherapy for Triple-negative Breast Cancer: A Retrospective, Real-world Study From Multiple Centers in London, UK.
Journal: Clinical breast cancer
Published: January 06, 2026
A Five-Year Retrospective Analysis of Neoadjuvant Therapy in Early-Stage Breast Cancer: Subtype Outcomes and Imaging Concordance.
Journal: The breast journal
Published: October 15, 2025
The safety and clinical impact of ultra-low-dose FDG-PET imaging in pregnancy-associated breast cancer: the experience of a major tertiary oncology referral centre in the UK and suggested imaging protocol.
Journal: Nuclear medicine communications
Published: June 04, 2025
Expert UK consensus on the definition of high risk of recurrence in HER2-negative early breast cancer: A modified Delphi panel.
Journal: Breast (Edinburgh, Scotland)
Published: April 19, 2023
A Multicentre Retrospective Study of Fulvestrant Use and Efficacy in Advanced/Metastatic Breast Cancer.
Journal: Clinical oncology (Royal College of Radiologists (Great Britain))
Published: May 17, 2021
Cardiovascular Disease Amongst Women Treated for Breast Cancer: Traditional Cytotoxic Chemotherapy, Targeted Therapy, and Radiation Therapy.
Journal: Current cardiology reports
Published: January 08, 2021
Outcomes of the 2019 novel coronavirus in patients with or without a history of cancer: a multi-centre North London experience.
Journal: Therapeutic advances in medical oncology
Published: June 08, 2020
The impact of Oncotype DX breast cancer assay results on clinical practice: a UK experience.
Journal: Breast cancer research and treatment
Published: November 13, 2019
Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: October 05, 2018
Switching from standard to dose-dense chemotherapy in front-line treatment of advanced ovarian cancer: a retrospective study of feasibility and efficacy.
Journal: ESMO open
Published: October 25, 2016
Cediranib in patients with relapsed platinum-sensitive ovarian cancer (ICON6): a randomised, double-blind, placebo-controlled phase 3 trial.
Journal: Lancet (London, England)
Published: March 31, 2016
Last Updated: 09/26/2026